<code id='6A231C7600'></code><style id='6A231C7600'></style>

<acronym id='6A231C7600'></acronym>

<center id='6A231C7600'><center id='6A231C7600'><tfoot id='6A231C7600'></tfoot></center><abbr id='6A231C7600'><dir id='6A231C7600'><tfoot id='6A231C7600'></tfoot><noframes id='6A231C7600'>

<optgroup id='6A231C7600'><strike id='6A231C7600'><sup id='6A231C7600'></sup></strike><code id='6A231C7600'></code></optgroup>

<b id='6A231C7600'><label id='6A231C7600'><select id='6A231C7600'><dt id='6A231C7600'><span id='6A231C7600'></span></dt></select></label></b><u id='6A231C7600'></u>

~~<i id='6A231C7600'><strike id='6A231C7600'><tt id='6A231C7600'><pre id='6A231C7600'></pre></tt></strike></i>~~

Home» leisure time» hotspot

hotspot

hotspot

author：leisure time 2025-09-06 16:02:47 Page View：397

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

advertisement

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 'Ancient DNA,' 23andMe reveal African American ancestries
Next article： After affirmative action ruling, medical educators look to 'holistic review'

explore

Dobbs anniversary: the lost opportunity of abortion as health care

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

CDC: Cases of alpha

CDC: Cases of alpha

AlonestartickunderamicroscopeinalabattheNorthCarolinaMuseumofNaturalSciencesinRaleigh.Doctorsacrosst

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

The drug industry sees a key ally in the Senate prevail

NorthCarolinaSenatorRichardBurrreceivedstrongsupportfromthebiotechsector.GerryBroome/APWASHINGTON—Av

read more